Hematology TimesSB-generated CAR T cells show promiseAugust 5, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationALLNon-Hodgkin Lymphoma
Hematology TimesCompounds can fight lymphoma, other cancersJuly 29, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesLenalidomide maintenance doesn’t improve OS in DLBCLJuly 27, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesEC grants immunotherapy orphan designationJuly 22, 2016Lymphoma & Plasma Cell DisordersPharmacyTransplantationHodgkin LymphomaNon-Hodgkin Lymphoma
Hematology TimesIbrutinib approved for first-line treatment of CLLJuly 21, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesCombo doesn’t improve PFS in DLBCLJuly 19, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesEC approves lenalidomide for rel/ref MCLJuly 16, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesDrug’s benefits outweigh risks, PRAC saysJuly 10, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesCancer cell lines predict drug response, study showsJuly 8, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLCMLNon-Hodgkin Lymphoma
Hematology TimesNHL patients may have higher risk of second cancerJuly 7, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesNew type of CAR T cells can produce responses in NHLJuly 1, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin Lymphoma
Hematology TimesCombo shows promise for treating DLBCLJune 30, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesTeam maps chromatin landscape in CLLJune 28, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesCHMP rejects ofatumumab as maintenanceJune 26, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesObinutuzumab approved to treat FLJune 19, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaFollicular Lymphoma
